Qiagen N.V. (ETR:QIA)
Germany · Delayed Price · Currency is EUR | Market Cap | 8.16B |
| Revenue (ttm) | 1.76B |
| Net Income (ttm) | 345.50M |
| Shares Out | n/a |
| EPS (ttm) | 1.57 |
| PE Ratio | 23.61 |
| Forward PE | 17.61 |
| Dividend | 1.42 (3.80%) |
| Ex-Dividend Date | Jul 2, 2025 |
| Volume | 568,826 |
| Average Volume | 436,973 |
| Open | 37.44 |
| Previous Close | 37.36 |
| Day's Range | 36.99 - 37.66 |
| 52-Week Range | 34.24 - 47.36 |
| Beta | 0.66 |
| RSI | 28.24 |
| Earnings Date | Nov 4, 2025 |
About Qiagen
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and... [Read more]
Financial Performance
In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.
Financial numbers in USD Financial StatementsNews
Seattle's Parse Biosciences to be acquired by Qiagen for $225M
Seattle's Parse Biosciences is teed up for an acquisition by Qiagen, a Netherlands-based holding company, in a $225 million cash
Relative Strength Alert For Qiagen
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a tec...
Qiagen NV (QGEN) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ...
Qiagen NV (QGEN) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Strategic Acquisitions Propel Future Outlook
Qiagen signals $2.38 adjusted EPS target and $500M share repurchase while advancing single-cell strategy
Discover Qiagen's Q3 2025 earnings call highlights: strong core growth, AI-driven Parse acquisition, raised EPS outlook, and major shareholder returns.
Qiagen N.V. (QGEN) Q3 2025 Earnings Call Transcript
Q3 2025 Qiagen NV Earnings Call Transcript
Q3 2025 Qiagen NV Earnings Call Transcript
Qiagen NV Q3 25 Earnings Conference Call At 9:30 AM ET
(RTTNews) - Qiagen NV (QGENF) will host a conference call at 9:30 AM ET on November 5, 2025, to discuss Q3 25 earnings results.
Qiagen NV Profit Rises In Q3
(RTTNews) - Qiagen NV (QGENF) on Tuesday reported third-quarter net income of $130 million or $0.60 per share, compared to $98 million or $0.44 per share last year.
Here's What Key Metrics Tell Us About Qiagen (QGEN) Q3 Earnings
Although the revenue and EPS for Qiagen (QGEN) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Stre...
Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates
Qiagen (QGEN) delivered earnings and revenue surprises of +5.17% and +1.25%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
QGEN Crosses Below Key Moving Average Level
In trading on Tuesday, shares of Qiagen NV (Symbol: QGEN) crossed below their 200 day moving average of $44.79, changing hands as low as $43.26 per share. Qiagen NV shares are currently trading off ab...
Qiagen Non-GAAP EPS of $0.61 beats by $0.02, revenue of $533M beats by $7.09M
Qiagen Q3 results: EPS and revenue beat estimates, strong growth in QIAstat-Dx & QuantiFERON. 2025 outlook raised.
Qiagen (QGEN) to Acquire Parse Biosciences, Boosting Single-Cell Research Capabilities
Qiagen (QGEN) to Acquire Parse Biosciences, Boosting Single-Cell Research Capabilities
Qiagen (QGEN) Raises Earnings Outlook for 2025
Qiagen (QGEN) Raises Earnings Outlook for 2025
QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results for the third quarter of 2025 and reaffirmed its outlook for solid profitable growth while raising its profitability tar...
QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results for the third quarter of 2025 and reaffirmed its outlook for soli...
QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions
VENLO, Netherlands & SEATTLE--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has entered into a definitive agreement to fully acquire Parse Bi...
EQS-Adhoc: QIAGEN N.V.: QIAGEN announces CEO transition plan
EQS-Ad-hoc: QIAGEN N.V. / Key word(s): Personnel QIAGEN N.V.: QIAGEN announces CEO transition plan 04-Nov-2025 / 19:02 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regula...
EQS-Adhoc: QIAGEN N.V.: QIAGEN to return approximately $500 million to shareholders through a synthetic share repurchase
EQS-Ad-hoc: QIAGEN N.V. / Key word(s): Share Buyback QIAGEN N.V.: QIAGEN to return approximately $500 million to shareholders through a synthetic share repurchase 04-Nov-2025 / 19:00 CET/CEST Disclosu...
Qiagen NV (QGEN) Q3 2025 Earnings Report Preview: What To Expect
Qiagen NV (QGEN) Q3 2025 Earnings Report Preview: What To Expect
Qiagen Q3 2025 Earnings Preview
Get the latest on Qiagen (QGEN) Q3 earnings, with analyst estimates, revision trends, and a history of beating forecasts.
Noteworthy Monday Option Activity: MP, QGEN, ROOT
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in MP Materials Corp (Symbol: MP), where a total volume of 88,976 contracts has been ...
Qiagen NV (QGEN) Q3 2025: Everything You Need to Know Ahead of Earnings
Qiagen NV (QGEN) Q3 2025: Everything You Need to Know Ahead of Earnings
QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing
VENLO, Netherlands, & GERMANTOWN, Maryland--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the 4,000th placement of its QIAcube Connect instrumen...
QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the third quarter of 2025. Press release date / time: Tuesday...